Back

Incidence and significance of early AF recurrences with the second generation cryoballoon: insights from the STOP-AF post approval study

20 June 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Atrial Fibrillation - Catheter ablation Catheter ablation (Atrial Fibrillation) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Mr Robert Hokanson

Medtronic, Minneapolis (United States of America)

52 More presentations in this session

Presentation thumbnail
Doctor N. Watanabe (Tokyo, JP)
Abstract
Presentation thumbnail
Doctor M. Mizobuchi (Kyoto, JP)
Abstract Slides
Presentation thumbnail
Doctor M. Wolf (Antwerp, BE)
Abstract
Presentation thumbnail
Doctor O. Sultan (Regina, CA)
Abstract Slides
Presentation thumbnail
Doctor T. Nagase (Tokyo, JP)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Atrial Fibrillation - Catheter ablation

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

20 June 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Long-term recurrence-free survival following second-generation cryoballoon ablation for persistent atrial fibrillation: role of the autonomic nervous system
8 April 2024
thumbnail
Congress Presentation
Incidence of atrial fibrillation after haematopoietic stem cell transplantation: the COAST-AF study
30 August 2025
thumbnail
Congress Presentation
Incidence, characteristics, and prognostic impact of cancers in patients with atrial fibrillation: a report from the GLORIA-AF registry
2 September 2024
thumbnail
Congress Presentation
Preprocedural atrial fibrillation burden is associated with recurrence in patients undergoing atrial fibrillation ablation: findings from the ISOLATION AF Ablation Cohort Study
7 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources